PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy. l.calabro@ao-siena.toscana.it.\', \'EPigenetic Immune-Oncology Consortium Airc (EPICA), Viale Mario Bracci, 16; 53100, Siena, Italy. l.calabro@ao-siena.toscana.it.\', \'Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.\', \'EPigenetic Immune-Oncology Consortium Airc (EPICA), Viale Mario Bracci, 16; 53100, Siena, Italy.\', \'University of Siena, Siena, Italy.\', \'IRCCS SDN, Naples, Italy.\', \'Fondazione NIBIT Onlus, Siena, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11912-021-01125-8
?:hasPublicationType
?:journal
  • Current oncology reports
is ?:pmid of
?:pmid
?:pmid
  • 34677721
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.144
?:rankingScore_hIndex
  • 48
is ?:relation_isRelatedTo_publication of
?:title
  • COVID and Lung Cancer.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all